First Trust Advisors’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
First Trust Advisors's NEO Position: Q2 2026 in Review
First Trust Advisors increased its NeoGenomics (NEO) stake by 64% in Q2 2026, buying an estimated $38.1M and bringing the position to 10,113,261 shares worth $148M. The position accounts for 0.09% of the portfolio, ranked #278.
First Trust Advisors first reported a position in NEO in Q4 2018 and has held it in 23 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- First Trust Advisors held 10,113,261 shares of NeoGenomics worth $148M as of Q2 2026.
- First Trust Advisors bought 3,950,890 NeoGenomics shares in Q2 2026, an estimated $38.1M.
- NeoGenomics made up 0.09% of First Trust Advisors's portfolio in Q2 2026, its #278 holding.
- First Trust Advisors first reported a position in NeoGenomics in Q4 2018 and has held it in 23 quarters since.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.